＜Research＞Citi Opens Downside 30D Catalyst Watch on CR MEDICAL (01515.HK)

　　Citi Research opened Downside 30-Day Catalyst Watch on CR MEDICAL (01515.HK) +0.020 (+0.641%) Short selling $354.31K; Ratio 3.186% , expecting the company's 1H24 results to be a disappointment to the market mainly due to factors including the potential impairment of Huaiyin Hospital and slower-than-expected growth in revenue of China Resources Healthcare (Liaoning), according to a recent Citi Research report.

　　Expecting CR MEDICAL's share price to react negatively to the pressure on its results, the broker set the TP at $7 with a Buy rating.

　　(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2024-07-25 16:25.)

　　AAStocks Financial News